Tatiana Ramey
Biographic Data
| ID | 7861899 |
|---|---|
| NAME | Tatiana Ramey |
| GIVEN NAMES | Tatiana |
| FAMILY NAME | Ramey |
| SIGNATURE | RAMEY T |
| AFFILIATIONS | National Institute on Drug Abuse |
| ORCID | 0000-0002-1909-2385 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Initial Validation of a Behavioral Phenotyping Model for Substance Use Disorder
Standard nosological systems, such as DSM-5 or ICD-10, are relied upon as the diagnostic basis when developing treatments for individuals with substance use disorder (SUD). Unfortunately, the vast heterogeneity of individuals within a given SUD diagnosis results in a variable treatment response and/or difficulties ascertaining the efficacy signal in clinical trials of drug development. Emerging precision medicine methods focusing on targeted trea…
Sex Specific Sleep Parameters Among People With Substance Use Disorder
Sleep holds promise as an avenue to address SUD within a biopsychosocial model. Future work at the intersection of SUD and sleep should prioritize investigations of their interplay with sex to identify targets for tailored SUD interventions
Safety and Preliminary Efficacy of Lorcaserin for Cocaine Use Disorder
Background and Objectives: Preclinical studies show serotonin (5-HT) 5-HT 2C receptor (5-HT 2C R) agonists reduce cocaine-seeking and cocaine intake. This study examined safety of the 5-HT 2C R agonist lorcaserin administered with cocaine in participants with cocaine use disorder (CocUD). Secondarily, subjective response to cocaine and choice of cocaine vs. money were examined. Methods: A double-blind, randomized, placebo-controlled trial of 25 i…
Social Information Processing in Substance Use Disorders
Positive social connections are crucial for recovery from Substance Use Disorder (SUD). Of interest is understanding potential social information processing (SIP) mediators of this effect. To explore whether persons with different SUD show idiosyncratic biases toward social signals, we administered an emotional go-nogo task (EGNG) to 31 individuals with Cocaine Use Disorder (CoUD), 31 with Cannabis Use Disorder (CaUD), 79 with Opioid Use Disorder…
No prominent works on this page.
Safety and Preliminary Efficacy of Lorcaserin for Cocaine Use Disorder
Background and Objectives: Preclinical studies show serotonin (5-HT) 5-HT 2C receptor (5-HT 2C R) agonists reduce cocaine-seeking and cocaine intake. This study examined safety of the 5-HT 2C R agonist lorcaserin administered with cocaine in participants with cocaine use disorder (CocUD). Secondarily, subjective response to cocaine and choice of cocaine vs. money were examined. Methods: A double-blind, randomized, placebo-controlled trial of 25 i…
Social Information Processing in Substance Use Disorders
Positive social connections are crucial for recovery from Substance Use Disorder (SUD). Of interest is understanding potential social information processing (SIP) mediators of this effect. To explore whether persons with different SUD show idiosyncratic biases toward social signals, we administered an emotional go-nogo task (EGNG) to 31 individuals with Cocaine Use Disorder (CoUD), 31 with Cannabis Use Disorder (CaUD), 79 with Opioid Use Disorder…
Sex Specific Sleep Parameters Among People With Substance Use Disorder
Sleep holds promise as an avenue to address SUD within a biopsychosocial model. Future work at the intersection of SUD and sleep should prioritize investigations of their interplay with sex to identify targets for tailored SUD interventions
Initial Validation of a Behavioral Phenotyping Model for Substance Use Disorder
Standard nosological systems, such as DSM-5 or ICD-10, are relied upon as the diagnostic basis when developing treatments for individuals with substance use disorder (SUD). Unfortunately, the vast heterogeneity of individuals within a given SUD diagnosis results in a variable treatment response and/or difficulties ascertaining the efficacy signal in clinical trials of drug development. Emerging precision medicine methods focusing on targeted trea…
Psychiatry (4 works) · Psychology (4 works) · Clinical Psychology (3 works) · Clinical Psychology (3 works) · Addiction (2 works) · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 works) · Cognition (2 works) · Medicine (2 works) · Mental Health Research Topics (2 works) · Substance abuse (2 works)